Open Accessibility Menu

Clinical Trial Information

BESPOKE Study of ctDNA Guided Immunotherapy
  • Category: Colorectal, Melanoma, Non-small Cell Lung Cancer
  • Status: Active

Description of Trial:

This is a prospective data collection study of patients with advanced solid tumors who will receive standard of care immunotherapy (IO) and will be monitored with SIGNATERA™ testing. SIGNATERA™ test will be performed at baseline and during routine care. The test results will be part of assessing tumor response. The correlation between SIGNATERA™ test results and subsequent treatment decisions will be examined to compare actual treatment delivered against treatment decisions potentially impacted by SIGNATERA™ results. Treatment administered, tumor assessment results, time to progression, overall survival, physician questionnaires, and patient-reported outcomes will be collected/recorded. 

For all information regarding this clinical trial please visit: